Corient Capital Partners, LLC Health Catalyst, Inc. Transaction History
Corient Capital Partners, LLC
- $1.34 Billion
- Q3 2022
A detailed history of Corient Capital Partners, LLC transactions in Health Catalyst, Inc. stock. As of the latest transaction made, Corient Capital Partners, LLC holds 10,805 shares of HCAT stock, worth $48,082. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,805
Previous 10,805
-0.0%
Holding current value
$48,082
Previous $157,000
-0.0%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding HCAT
# of Institutions
176Shares Held
50.5MCall Options Held
2.97MPut Options Held
16.1K-
Black Rock Inc. New York, NY5.43MShares$24.2 Million0.0% of portfolio
-
First Light Asset Management, LLC Edina, MN5.24MShares$23.3 Million3.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.39MShares$19.6 Million0.0% of portfolio
-
Impax Asset Management Group PLC2.75MShares$12.2 Million0.1% of portfolio
-
Daventry Group, LP New York, NY2.51MShares$11.2 Million6.78% of portfolio
About Health Catalyst, Inc.
- Ticker HCAT
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 54,723,400
- Market Cap $244M
- Description
- Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accura...